BRIEF published on 02/20/2025 at 14:06, 11 months 12 days ago Mainz Biomed s'étend en Suisse avec un nouveau partenariat Mayence Biomed Dépistage Du Cancer Colorectal Alerte Colo L'expansion De La Suisse Diagnostic ADN
PRESS RELEASE published on 02/20/2025 at 14:01, 11 months 12 days ago Mainz Biomed Expands into Switzerland with labor team w Mainz Biomed partners with labor team in Switzerland to launch DNA-based colorectal cancer screening test, expanding presence in European market Switzerland Mainz Biomed Colorectal Cancer Labor Team DNA-based Test
BRIEF published on 02/11/2025 at 14:06, 11 months 21 days ago Mainz Biomed et GANZIMMUN lancent le dépistage amélioré ColoAlert Innovation Dans Le Domaine De La Santé Dépistage Du Cancer Lancement De ColoAlert Directives Pour L'Allemagne Tampon D'ADN
BRIEF published on 02/11/2025 at 14:06, 11 months 21 days ago Mainz Biomed and GANZIMMUN Launch Enhanced ColoAlert Screening Healthcare Innovation Cancer Screening ColoAlert Launch Germany Guidelines DNA Buffer
PRESS RELEASE published on 02/11/2025 at 14:01, 11 months 21 days ago Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month Mainz Biomed and GANZIMMUN launch enhanced ColoAlert colorectal cancer screening ahead of awareness month, providing broader access and innovative diagnostics Germany ColoAlert Mainz Biomed Colorectal Cancer Screening GANZIMMUN
BRIEF published on 01/27/2025 at 14:06, 1 year ago Mainz Biomed retrouve sa conformité au Nasdaq ColoAlert® Mayence Biomed Conformité Au Nasdaq Diagnostic Du Cancer Exigences En Matière De Fonds Propres
BRIEF published on 01/27/2025 at 14:06, 1 year ago Mainz Biomed Regains Nasdaq Compliance Nasdaq Compliance Cancer Diagnostics Mainz Biomed ColoAlert® Equity Requirements
PRESS RELEASE published on 01/27/2025 at 14:01, 1 year ago Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements Mainz Biomed N.V. regains compliance with Nasdaq Capital Market listing requirements. The company is now in full compliance with all Nasdaq continued listing requirements Compliance Nasdaq Capital Market Mainz Biomed N.V. Stockholders' Equity Listing Requirements
BRIEF published on 01/21/2025 at 14:06, 1 year ago Mainz Biomed lance une étude américaine sur la détection avancée des adénomes Cancer Colorectal Biomarqueurs Mayence Biomed Étude Clinique Détection Précoce 2
BRIEF published on 01/21/2025 at 14:06, 1 year ago Mainz Biomed Launches U.S. Study for Advanced Adenoma Detection Clinical Study Mainz Biomed Colorectal Cancer Biomarkers EAArly DETECT 2
Published on 02/05/2026 at 09:05, 36 minutes ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 8 hours 6 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 9 hours 41 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 11 hours 16 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/05/2026 at 09:00, 40 minutes ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 40 minutes ago Original-Research: Limes Schlosskliniken AG (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 40 minutes ago Original-Research: Semperit AG Holding (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 41 minutes ago Novem Group S.A.: Q3 2025/26 shows steady Series sales
Published on 02/04/2026 at 18:04, 15 hours 37 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 15 hours 37 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 15 hours 56 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 15 hours 56 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
